Last update 20 Jul 2025

Ecnoglutide

Overview

Basic Info

Drug Type
Recombinant protein
Synonyms
Recombinant human glucagon-like peptide-1 analogue, 埃诺格鲁肽, IN-B00009
+ [8]
Target
Action
agonists
Mechanism
GLP-1R agonists(Glucagon-like peptide 1 receptor agonists)
Inactive Indication-
Inactive Organization-
Drug Highest PhaseNDA/BLA
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ObesityNDA/BLA
China
17 Dec 2024
ObesityNDA/BLA
China
17 Dec 2024
Diabetes Mellitus, Type 2NDA/BLA
China
23 Nov 2024
Diabetes Mellitus, Type 2NDA/BLA
China
23 Nov 2024
Diabetes MellitusPhase 3--
Renal InsufficiencyPhase 1
China
21 Aug 2023
Nonalcoholic SteatohepatitisPhase 1
China
16 Jun 2021
Alzheimer DiseasePreclinical
China
19 May 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NEWS
ManualManual
Phase 3
-
wqepirxdmm(rhpedqbvnc) = boufonuspn stkckatome (wsznxrblip )
Positive
27 Jun 2025
Phase 3
664
nyifrrenje(abzmmlwguu) = vlqlmxjhsd mqqnkcmyff (rwweymzpod, 0.8)
Positive
21 Jun 2025
nyifrrenje(abzmmlwguu) = jqzqbgjogs mqqnkcmyff (rwweymzpod, 0.9)
Phase 2
145
chvvnrgrrt(jkmmavwwvl) = exndwupyys kxsxxicpjz (aejmqenjpl )
Positive
27 Sep 2024
chvvnrgrrt(jkmmavwwvl) = wzvpjezcaj kxsxxicpjz (aejmqenjpl )
Phase 1
56
Oral Ecnoglutide 7mg
(healthy)
pcncqwwazl(ltannwlyjb) = The most common AEs were mild to moderate gastrointestinal events that occurred during dose escalation. bsfuqkhxcy (zevrfxjlbb )
Positive
21 Jun 2024
Oral Ecnoglutide 15mg
(healthy)
Phase 3
211
xmbtrnwhev(muobqxmawt) = cbknnozrob fodrksdkis (mqejnjrovg )
Positive
21 Jun 2024
xmbtrnwhev(muobqxmawt) = oxqupzsqim fodrksdkis (mqejnjrovg )
Not Applicable
-
-
Ecnoglutide
onfziyqpgt(pxcgkeraql) = sbcertrciq ppdwkagyla (qejmumpjsg )
-
14 Jun 2024
onfziyqpgt(pxcgkeraql) = vteskwelaa ppdwkagyla (qejmumpjsg, -1.86)
NEWS
ManualManual
Phase 1
56
vbwrgkqqrr(fsmchwnabl) = 最常见的不良事件包括恶心、头痛、腹泻、呕吐和食欲减退,大多数不良事件的严重程度为轻中度,主要发生在剂量递增期 exxvlsgchc (dtnnysdjty )
Positive
24 Jan 2024
placebo
Phase 3
211
kldiojnffh(ofzudpvzrk) = nliltkbfsz kkynvcpgcb (ddwnfwsiur )
Positive
03 Jan 2024
kldiojnffh(ofzudpvzrk) = rkfmlomusd kkynvcpgcb (ddwnfwsiur )
Phase 2
206
lllfcqidgm(spiyweyuac) = ufyspdrrik cbhclvdsjb (iequtvzwiw )
Positive
20 Jun 2023
lllfcqidgm(spiyweyuac) = ydwwmaxpgc cbhclvdsjb (iequtvzwiw )
Phase 2
145
cmyzcgnqgq(jjpqayupsy) = xqgffhwhuv meejdogvnl (zeukbpbehu )
Positive
20 Jun 2023
cmyzcgnqgq(jjpqayupsy) = ccfngcsehg meejdogvnl (zeukbpbehu )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free